On September 25, 2009
Why Merck’s Gardasil Franchise Will Be Battered by Entry of GSK’s Cervarix
Merck CEO Richard Clark thinks there’s still plenty of steam left in the Gardasil franchise now it’s lost its monopoly status as the only HPV vaccine on the market. But Merck’s own sales numbers show a disaster looming for Gardasil.
0 Comments